DK2828292T3 - Jcv-neutraliserende antistoffer - Google Patents

Jcv-neutraliserende antistoffer

Info

Publication number: DK2828292T3
Authority: DK; Denmark
Prior art keywords: jcv; neutralizing antibodies; neutralizing; antibodies
Prior art date: 2012-03-20

Application number

DK13763643.7T

Other languages

English (en)

Inventor

Kenneth Simon

Thomas Cameron

Mia Rushe

George Campbell Kaynor

Justin Caravella

Original Assignee

Biogen Ma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-03-20

Filing date

2013-03-15

Publication date

2019-01-02

2013-03-15 Application filed by Biogen Ma Inc filed Critical Biogen Ma Inc

2019-01-02 Application granted granted Critical

2019-01-02 Publication of DK2828292T3 publication Critical patent/DK2828292T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

DK13763643.7T 2012-03-20 2013-03-15 Jcv-neutraliserende antistoffer DK2828292T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201261613249P	2012-03-20	2012-03-20
PCT/US2013/031853 WO2013142300A2 (en)	2012-03-20	2013-03-15	Jcv neutralizing antibodies

Publications (1)

Publication Number	Publication Date
DK2828292T3 true DK2828292T3 (da)	2019-01-02

Family

ID=49223445

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK13763643.7T DK2828292T3 (da)	2012-03-20	2013-03-15	Jcv-neutraliserende antistoffer

Country Status (6)

Country	Link
US (1)	US9567391B2 (da)
EP (1)	EP2828292B1 (da)
CA (1)	CA2867910C (da)
DK (1)	DK2828292T3 (da)
ES (1)	ES2706173T3 (da)
WO (1)	WO2013142300A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2867902C (en)	2012-03-20	2023-09-26	Biogen Idec Ma Inc.	Jcv neutralizing antibodies
ITTO20120570A1 (it) *	2012-06-27	2013-12-28	Pomona Ricerca Srl	Anticorpo monoclonale diretto contro il virus jc
CA2896824A1 (en)	2012-12-31	2014-07-03	Neurimmune Holding Ag	Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases
US9931393B2 (en)	2013-12-20	2018-04-03	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Immunogenic JC polyomavirus compositions and methods of use
US9862760B2 (en) *	2015-09-16	2018-01-09	Novartis Ag	Polyomavirus neutralizing antibodies
JP2021508439A (ja) *	2017-12-01	2021-03-11	ノバルティスアーゲー	ポリオーマウイルス中和抗体
WO2020119793A1 (en) *	2018-12-14	2020-06-18	Wuxi Biologics (Shanghai) Co., Ltd.	Humanized antibodies against ox40, method for preparing the same, and use thereof
WO2020257633A2 (en) *	2019-06-19	2020-12-24	Icahn School Of Medicine At Mount Sinai	Monoclonal antibodies against jc virus
KR20230004725A (ko) *	2020-04-22	2023-01-06	아케소 바이오파마, 인크.	항-cd73 항체 및 이의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2386367T3 (es)	2005-03-10	2012-08-17	Morphotek, Inc.	Anticuerpos anti-mesotelina
CN105111311B (zh)	2005-12-20	2019-10-18	Sbi生物技术有限公司	抗ilt7抗体
WO2007139359A1 (en)	2006-05-31	2007-12-06	Hanwha Chemical Corporation	Vcam-1 specific monoclonal antibody
US7910702B2 (en) *	2006-07-28	2011-03-22	The Governors Of The University Of Alberta	Recombinant antibodies to sclerotinia antigens
WO2008118013A2 (en)	2007-03-23	2008-10-02	To-Bbb Holding B.V.	Targeted intracellular delivery of antiviral agents
WO2009023386A2 (en)	2007-07-06	2009-02-19	Trubion Pharmaceuticals, Inc.	Binding peptides having a c-terminally disposed specific binding domain
CA2727992C (en)	2008-06-25	2017-10-17	Esbatech, An Alcon Biomedical Research Unit Llc	Stable and soluble antibodies inhibiting tnf.alpha.
AU2010210979B2 (en) *	2009-02-05	2015-12-10	Biogen Ma Inc.	Methods for the detection of JC polyoma virus
WO2010129959A1 (en)	2009-05-08	2010-11-11	Government Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services	Compositions and methods for the prevention and treatment of lupus nephritis using anti-dsdna germline antibodies
EP2316481A1 (en)	2009-10-30	2011-05-04	Biomay Ag	Pharmaceutical composition for the treatment and prevention of a rhinovirus infection
CA2867902C (en)	2012-03-20	2023-09-26	Biogen Idec Ma Inc.	Jcv neutralizing antibodies

2013
- 2013-03-15 US US14/386,228 patent/US9567391B2/en active Active
- 2013-03-15 ES ES13763643T patent/ES2706173T3/es active Active
- 2013-03-15 DK DK13763643.7T patent/DK2828292T3/da active
- 2013-03-15 EP EP13763643.7A patent/EP2828292B1/en active Active
- 2013-03-15 CA CA2867910A patent/CA2867910C/en active Active
- 2013-03-15 WO PCT/US2013/031853 patent/WO2013142300A2/en active Application Filing

Also Published As

Publication number	Publication date
CA2867910A1 (en)	2013-09-26
EP2828292A2 (en)	2015-01-28
WO2013142300A3 (en)	2013-11-14
WO2013142300A2 (en)	2013-09-26
US9567391B2 (en)	2017-02-14
US20150056188A1 (en)	2015-02-26
ES2706173T3 (es)	2019-03-27
EP2828292B1 (en)	2018-10-31
EP2828292A4 (en)	2016-03-30
CA2867910C (en)	2023-09-26

Publication	Publication Date	Title
DK2934584T3 (da)	2020-05-18	Anti-gdf15-antistoffer
DK2850101T3 (da)	2019-07-15	Anti-FcRn-antistoffer
CO7020871A2 (es)	2014-08-11	Anticuerpos anti-il-36r
DK2859055T3 (da)	2021-02-22	Polymercoatings
DK2825087T3 (da)	2019-05-13	Otoscanner
DK2839013T3 (da)	2020-09-14	Ikke-disruptiv-gen-targetering
DK2873977T3 (da)	2020-06-08	Dobbeltdækker-rørdispenser
DE112012006109A5 (de)	2014-12-18	Okklusionsschienenanordnung
DK2854722T3 (da)	2020-08-24	Stomipose
BR112014025037A2 (pt)	2018-07-31	anticorpo ou um fragmento funcional do mesmo, nucleotídeo, vetor recombinante, célula, métodos para a produção de um anticorpo ou fragmento funcional, para detecção ou ensaio de fgfr2 humano iiib, para a identificação de um indivíduo receptor de uma composição farmacêutica, e, para identificar e para produzir uma substância, forma modificada, composição, e, reagente
DK2825157T3 (da)	2019-01-02	Aminosyrelipider
DK2828292T3 (da)	2019-01-02	Jcv-neutraliserende antistoffer
DK3431504T3 (da)	2021-06-28	Antiphospholipase d4-antistof
DK2931748T3 (da)	2017-01-02	Bmp-6-antistoffer
DK2831122T3 (da)	2016-05-17	Anthocyanidin-kompleks
CL2014003125A1 (es)	2015-08-21	Anticuerpos de anti-transglutaminasa 2
DE112012006214T8 (de)	2015-04-16	Wulstringwickler
DK2935330T3 (da)	2019-07-22	Anti-notch3-antistoffer
CO6841994A2 (es)	2014-01-20	Anticuerpos
DE112012005566T8 (de)	2014-11-13	Seltenerdnanoverbundmagnet
FI20126082A (fi)	2014-04-19	Kaasunvaihtoventtiilijärjestely
DK2885638T3 (da)	2020-07-20	Molekylenet
DK2858657T3 (da)	2020-11-23	Feijoafrugtekstrakt
FI20126157A (fi)	2014-05-02	Laajentumistila
FI20125844A (fi)	2014-02-15	Talotekniikkamoduuli